Ramosetron

DB09290InvestigationalSmall molecule

Ramosetron is a selective 5-HT3 antagonist used as an antiemetic for chemotherapy- and postoperative-associated nausea and vomiting. It may also possess efficacy in irritable bowel syndrome. Ramosetron is a serotonin 5-HT3 receptor antagonist commonly employed to treat nausea and vomiting, in addition to certain diarrheal conditions.

Chemical structure of Ramosetron
Primary indication
For the treatment of nausea and vomiting and diarrhea-predominant irritable bowel syndrome in males.Curator reviewed · 1 structured indication
Formula / weight
C17H17N3O · 279.343 g/mol (avg)
Code names
Nor-YM 060 · YM 060

Resolves to

Compound
UNII7ZRO0SC54YCAS132036-88-5ChEMBLCHEMBL1643895ChEBI135156PubChem108000KEGGD08466
Structure
InChIKeyNTHPAPBPFQJABD-LLVKDONJSA-NSMILESCN1C=C(C(=O)[C@@H]2CCC3=C(C2)N=CN3)C2=C1C=CC=C2
Targets
P46098HTR3A

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
997Drug interactionsStructured to mechanism, not free text
Sign in
48Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
7Marketed productsAcross 2 countries and 4 labellers
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Ramosetron, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In